No Detail Found!

Factors affecting adherence to Hepatitis C treatment at Tehsil Headquarter Hospital, Shuja Abad District Multan, Pakistan

Author(s)
Bushra Ijaz Departments of Community Medicine, Nishtar Medical University, Multan Pakistan
Mehreen Buhkari Departments of Community Medicine, Gujranwala Medical College, Gujranwala, Pakistan
Nadia Tufail Departments of Community Medicine, Nishtar Medical University, Multan Pakistan
Azra Shahaheen Departments of Community Medicine, Nishtar Medical University, Multan Pakistan
Syeda Asiya Abbas Naqvi Departments of Community Medicine, Nishtar Medical University, Multan Pakistan
Abstract
Objective: To determine the frequency of adherence to hepatitis C treatment and assessment of the factors that are associated with non-adherence to its treatment. Methodology: This descriptive cross-sectional was conducted at Tehsil Head Quarter Hospital, Shuja Abad District Multan from 1st August 2021 to 1st April 2022. A total of 173 participants with chronic hepatitis C taking antiviral medications were recruited through a non-probability convenient sampling technique. The Morisky Medication Adherence Scale (MMAS-8) was used to evaluate the level of adherence to treatment. Data analyses were done using SPSS version 25. Pearson chi-square was used to identify the variables linked to non-adherence to treatment. Results: Out of 173 patients, 12.7% had high adherence, 35.8% had medium adherence, and 51.4% had low adherence to treatment. We found that non-adherence to hepatitis C treatment was significantly associated with low education status, low income, smoking, duration of illness, co-morbid illnesses, and marital status. Conclusion: Non-adherence to hepatitis C treatment is highly prevalent among hepatitis C patients. Understanding patients’ socio-demographic factors and appropriate counselling services is important in achieving high adherence to hepatitis C treatment.
Publication Details
Page(s) 1-4
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 49, Issue: 4, Year: 2024

Request the full text from PASTIC

Keywords
Hepatitis C, Multan, Counselling, treatment., Adherence rate
References
Castaneda D,Gonzalez AJ,Alomari M,Tandon K,Zervos XB .2021 .From hepatitis A to E: A critical review of viral hepatitis. World J Gastroenterol, 27 : 1691-1715.
Hepatitis C . .[cited 2023 Feb6]. , : .
Razavi H,Sanchez Gonzalez Y,Yuen C,Cornberg M. .2019 .Global timing of hepatitis C virus elimination in high‐income countries. Liver Int, 40 : 522-9.
Alosaimi K,Alwafi H,Alhindi Y,Falemban A,Alshanberi A,Ayoub N .2022 .Medication adherence among patients with chronic diseases in Saudi Arabia. Int J Environ Res Public Health, 19 : 10053.
Mravcik V,Strada L,Stolfa J,Bencko V,Groshkova T,Reimer J .2013 .Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review. Patient Prefer Adherence, 7 : 1067-75.
Coco LT,Silva GF,Romeiro FG,Cerqueira AT .2022 .Factors associated with hepatitis C treatment adherence: an integrative review. Cienc Saude Coletiva, 27 : 1359-76.
World Hepatitis Day 2021: Hepatitis Can't Wait . .. , : .
. .-2021-hepatitis-cant-wait. World Health Organization. World Health Organization; [cited 2023 Jan, 25 : .
Mahmud S,Abu-Raddad Z,LJ Z .2019 .Characterization of the hepatitis C virus epidemic in Pakistan. BMC Infect Dis, 19 : 1-1.
Schwambach KH,Farias MR,Neto GB,Blatt CR .2020 .Cost, and effectiveness of the treatment of chronic hepatitis C in Brazil: Real-World Data. Value Health Reg Issues, 23 : 49-54.
Kind J,Maeschli B,Bruggmann P .2022 .How to set the agenda for hepatitis C: A theory-driven policy analysis. Health. Res Policy Syst, 20 : 20.
Malespin M,Harris C,Kanar O,Jackman K,Smotherman C,Johnston A .2019 .Barriers to treatment of chronic hepatitis C with direct acting antivirals in an urban clinic. Ann Hepatol, 18 : 304-9.
Ahmed MM,O. Shaarawy H,Anwar I,Sarhan MD .2021 .Barriers to Completing Therapy for Hepatitis C with Direct-Acting Antivirals: A Real-Life Experience from a Single Treatment Center in Egypt. J Prim Care Community Health, 12 : 1-6.
Morisky DE,Ang A,Krousel‐Wood M,Ward HJ .2008 .Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens, 10 : 348-54.
Clark PJ,Valery PC,Strasser SI,Weltman M,Thompson AJ,Levy M .2022 .Liver disease and poor adherence limit hepatitis C cure: a real-world Australian treatment cohort. Dig Dis Sci, 68 : 291-303.
Serper M,Evon DM,Stewart PW,Lok AS,Amador J,Reeve BB .2019 .Medication non-adherence in a prospective, multi-center cohort treated with hepatitis C direct-acting antivirals. J Gen Intern Med, 35 : 1011-20.
Ivantes CA,Silva BC,Acosta GG,Tawil FB,Nisihara R .2021 .Non-adherence to hepatitis C treatment: a Brazilian report. Arquivos de Gastroenterologia, 58 : 456-60.
Cooper CL,Galanakis C,Donelle J,Kwong J,Boyd R,Boucher L .2019 .HCV-infected individuals have higher prevalence of comorbidity and multimorbidity: a retrospective cohort study. BMC Infect Dis, 19 : 1-5.
Aleman S,Soderholm J,Busch K,Kovamees J,Duberg AS .2020 .Frequent loss to follow‐up after diagnosis of hepatitis C virus infection: A barrier towards the elimination of hepatitis C virus. Liver Int, 40 : 1832-40.
Pericot-Valverde I,Heo M,Akiyama MJ,Norton BL,Agyemang L,Niu J .2020 .Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: Secondary analysis of the prevail randomized clinical trial. BMC Infect Dis, 20 : 1-11.
Philip TJ,Crosby KM,Frank-Pearce SG,Wendelboe AM,Solberg M,Weakley J .2022 .Factors impacting medication adherence in a birth cohort at higher risk for Hepatitis C infection. Baltimore Md, 101 : e32354.
0

Citations

0

Downloads

41

Views